for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Luye Pharma Group Says IND Application Of LY03013 Accepted By CDE In China

June 18 (Reuters) - Luye Pharma Group Ltd:

* IND APPLICATION OF RIVASTIGMINE MULTI-DAY TRANSDERMAL PATCH (LY03013) ACCEPTED BY CDE IN CHINA Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up